Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study
- Author
- MAES, Bart D; OYEN, Raymond; CLAES, Kathleen; EVENEPOEL, Pieter; KUYPERS, Dirk; VANWALLEGHEM, Johan; VAN DAMME, Boudewijn; VANRENTERGHEM, Yves F. Ch
Department of Medicine, Division of Nephrology, University Hospital Gasthuisberg, Leuven, Belgium
Department of Radiology and Department of Pathology, University Hospital Gasthuisberg, Leuven, Belgium - Conference title
- Forefronts in nephrology: immunology in renal diseases
- Conference name
- Forefronts in Nephrology Symposium Immunology in Renal Disease (Berlin 2003-06-02)
- Author (monograph)
- GOLDMAN, Michel (Editor); SCHÖCKLMANN, Harald (Editor); KUNZENDORF, Ulrich (Editor)
International Society of Nephrology, International (Funder/Sponsor) - Source
Kidney international. 2004, Vol 65, Num 5, pp 1842-1849, 8 p ; ref : 34 ref
- CODEN
- KDYIA5
- ISSN
- 0085-2538
- Scientific domain
- Urology, nephrology
- Publisher
- Nature Publishing, New York, NY
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Author keyword
- IgA nephropathy immune disorder immunosuppression mycophenolate mofetil. renal function proteinuria
- Keyword (fr)
- Fonction rénale Immunodépression Mycophenolate mofetil Néphropathie à IgA Placebo Prospective Protéinurie Résultat Urologie Néphrologie Appareil urinaire pathologie
- Keyword (en)
- Renal function Immunosuppression Mycophenolate mofetil IgA Nephropathy Placebo Prospective Proteinuria Result Urology Nephrology Urinary system disease
- Keyword (es)
- Función renal Inmunodepresión Micofenolato mofetil Nefropatía IgA Placebo Prospectiva Proteinuria Resultado Urología Nefrología Aparato urinario patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14E Urinary system involvement in other diseases. Miscellaneous / 002B14E02 Urinary tract. Prostate gland
- Discipline
- Nephrology. Urinary tract diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 15710291
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1523-1755.2004.00588.x 
https://dx.doi.org/10.1111/j.1523-1755.2004.00588.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1523-1755.2004.00588.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Kidney international\";s:9:\"\u0000*\u0000stitle\";s:10:\"Kidney int\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"65\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1842\";s:8:\"\u0000*\u0000epage\";s:4:\"1849\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0085-2538\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"MAES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bart D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:13:\"OYEN, Raymond\";i:1;s:15:\"CLAES, Kathleen\";i:2;s:17:\"EVENEPOEL, Pieter\";i:3;s:13:\"KUYPERS, Dirk\";i:4;s:19:\"VANWALLEGHEM, Johan\";i:5;s:20:\"VAN DAMME, Boudewijn\";i:6;s:25:\"VANRENTERGHEM, Yves F. Ch\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"KDYIA5\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Forefronts in nephrology: immunology in renal diseases\";s:8:\"\u0000*\u0000title\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1523-1755.2004.00588.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Kidney international\";s:9:\"\u0000*\u0000stitle\";s:10:\"Kidney int\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"65\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1842\";s:8:\"\u0000*\u0000epage\";s:4:\"1849\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0085-2538\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"MAES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bart D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:13:\"OYEN, Raymond\";i:1;s:15:\"CLAES, Kathleen\";i:2;s:17:\"EVENEPOEL, Pieter\";i:3;s:13:\"KUYPERS, Dirk\";i:4;s:19:\"VANWALLEGHEM, Johan\";i:5;s:20:\"VAN DAMME, Boudewijn\";i:6;s:25:\"VANRENTERGHEM, Yves F. Ch\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"KDYIA5\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Forefronts in nephrology: immunology in renal diseases\";s:8:\"\u0000*\u0000title\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1523-1755.2004.00588.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1523-1755.2004.00588.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Kidney international\";s:9:\"\u0000*\u0000stitle\";s:10:\"Kidney int\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"65\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1842\";s:8:\"\u0000*\u0000epage\";s:4:\"1849\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0085-2538\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"MAES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bart D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:13:\"OYEN, Raymond\";i:1;s:15:\"CLAES, Kathleen\";i:2;s:17:\"EVENEPOEL, Pieter\";i:3;s:13:\"KUYPERS, Dirk\";i:4;s:19:\"VANWALLEGHEM, Johan\";i:5;s:20:\"VAN DAMME, Boudewijn\";i:6;s:25:\"VANRENTERGHEM, Yves F. Ch\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"KDYIA5\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Forefronts in nephrology: immunology in renal diseases\";s:8:\"\u0000*\u0000title\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1523-1755.2004.00588.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Kidney international\";s:9:\"\u0000*\u0000stitle\";s:10:\"Kidney int\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"65\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1842\";s:8:\"\u0000*\u0000epage\";s:4:\"1849\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0085-2538\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"MAES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bart D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:13:\"OYEN, Raymond\";i:1;s:15:\"CLAES, Kathleen\";i:2;s:17:\"EVENEPOEL, Pieter\";i:3;s:13:\"KUYPERS, Dirk\";i:4;s:19:\"VANWALLEGHEM, Johan\";i:5;s:20:\"VAN DAMME, Boudewijn\";i:6;s:25:\"VANRENTERGHEM, Yves F. Ch\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"KDYIA5\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Forefronts in nephrology: immunology in renal diseases\";s:8:\"\u0000*\u0000title\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1523-1755.2004.00588.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Kidney international\";s:9:\"\u0000*\u0000stitle\";s:10:\"Kidney int\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"65\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1842\";s:8:\"\u0000*\u0000epage\";s:4:\"1849\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0085-2538\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"MAES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bart D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:13:\"OYEN, Raymond\";i:1;s:15:\"CLAES, Kathleen\";i:2;s:17:\"EVENEPOEL, Pieter\";i:3;s:13:\"KUYPERS, Dirk\";i:4;s:19:\"VANWALLEGHEM, Johan\";i:5;s:20:\"VAN DAMME, Boudewijn\";i:6;s:25:\"VANRENTERGHEM, Yves F. Ch\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"KDYIA5\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Forefronts in nephrology: immunology in renal diseases\";s:8:\"\u0000*\u0000title\";s:109:\"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
